Navigation Links
Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression

he efficacy and tolerability of Cipralex(R) compared to duloxetine and its key findings include(1):

- Patients taking Cipralex(R) demonstrated significantly greater improvement in depression symptoms at week eight (acute treatment) than patients taking duloxetine. This superiority was evident after the first week of treatment and was maintained at all time points until week 16 (p<0.05)(1)

- Cipralex(R) was at least as effective as duloxetine at 24 weeks of treatment, the primary endpoint of the study (p=0.055)(1).

- Patients treated with Cipralex showed significantly better functioning in their work, family and social life at week 8 and week 24, compared to duloxetine(1)

- Cipralex(R) was better tolerated than duloxetine. Significantly more duloxetine patients withdrew from the study due to adverse events than those treated with Cipralex(R) (17 percent versus nine percent respectively)(1)

"Since current guidelines urge the long-term treatment of depression, it is vital that treatments offer the required efficacy coupled with acceptable tolerability," continued Dr Wade. "These new data add to the increasing evidence that Cipralex(R) may have a significant clinical advantage in this respect."

Notes to Editors

About the clinical study

The study was designed to look at the efficacy and tolerability of Cipralex(R) compared to duloxetine in patients with moderate to severe MDD over 24 weeks, with a secondary endpoint at eight weeks (acute treatment). The double-blind, fixed-dose, comparative study included 294 patients with MDD from 35 centres in nine countries. Patients were randomised to either Cipralex(R) (n=143) or duloxetine (n=151), at dosing regimens recommended in the package inserts in participating countries (Cipralex(R) 20mg, duloxetine 60mg)(1).

Efficacy (using the MADRS rating scale as the primary scale) and tolerability were assessed at baseline and after 1, 2, 4, 8, 12, 16, 20 and 24 weeks; a sa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
2. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
3. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
4. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
5. New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy
6. ECOG Phase III Newly Diagnosed Multiple Myeloma Trial (E4A03) Reports Lenalidomide Plus Low-Dose Dexamethasone Suggests Survival Advantage for Patients with Multiple Myeloma
7. MRI Detects Cancers in the Opposite Breast of Women Newly Diagnosed with Breast Cancer
8. Nymox Announces Positive Results from Newly Completed Long-term Study of NX-1207 for Benign Prostatic Hyperplasia
9. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder
10. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
11. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine

Post Your Comments:
(Date:11/25/2009)..., HARBIN, China, Nov. 25 /PRNewswire-Asia-F...ky One Medical" or "the Company") (Nasdaq: CSKI )...y developing and producing,over-the-counter drugs ...nnounced that the Company recently passed the Chin...utical and Biological Products ("ICPBP") examinati...
(Date:11/25/2009)..., EAST BRUNSWICK, N.J., Nov. 25 S... of direct digital Radiography ( ddR ) systems, an...ed by a private Swiss Investor with a long term vi...d. The acquisition included all assets and intelle.... After 25 years of success and growth Swissray is...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Pain Manag...nker.com/p0164220/Pain-Management---Global-Trends....gs, emergence of pain management clinics, and the ...rowth in the pain management market. Healthcare re...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 1Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 2Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 3Herbicide diversity needed to keep Roundup effective 9243 1Herbicide diversity needed to keep Roundup effective 9243 2Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 1Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 2
...d Community Oncology Research Network, Inc. Surpas...MEMPHIS, Tenn., March 31 The Accelerated Communit...nal oncology clinical trial,network, announced tod...xceeded performance expectations over the past 12 ...earch services to sponsors, from clinical,trial de...
... of Target Enrollment Expected in Fourth Quarter, ...ted (Nasdaq: GNTA ) announced that the Data Safet...ial of Genasense (oblimersen sodium),Injection, wh...commended,that the trial be continued as originall...ata from the study., AGENDA is a Phase 3, randomi...
Other Medicine Technology:ACORN's Oncology-focused Contract Research Organization Exceeds Projections 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4
(Date:11/27/2009)...RNewswire/ -- Allrecipes.com , the world,s #1 f...c numbers, with more than 2.8 million visitors the...e of what was served on the biggest food holiday o...weighed in at 2,225 calories per serving, a 5 perc...the Allrecipes site, Sweet Potato Pie I stole th...
(Date:11/27/2009)...ers who use medical load cells at the heart of the...ging in technology partner Flintec early in the de...ical manufacturers are calling in Flintec load cel...ensuring that progress will not be constrained by ...technology. , (PRWEB) Nov...
(Date:11/26/2009)...ire/ -- The diabetes population in the United Stat...nnual medical spending on the disease is projected...according to a study published in the December iss...betes ® Program (NCDP), a program of Novo Nor... University of Chicago. ,, According to the for...
(Date:11/26/2009)... strains or worse , , THURSDAY, Nov. 26 ...h stuffing your turkey full to bursting, but you m...ase as you pack for holiday trips. , More than ...l emergency rooms, doctors, offices, clinics and o...es, such as muscle strains, pulls and tears, accor...
(Date:11/26/2009)...Live Life Again Center, a practice offering weigh...ber of physicians who are taking advantage of pop...iduals who are interested in surgical weight loss ...izing Facebook to share before-and-after photos an...y. , Dallas, TX (Vocus) N...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...recommendation key to higher participation , ...ith a family history of colorectal cancer are less...nterparts or other blacks at average risk for the ...n though blacks have the highest rates of colorect...
...l/ - QLT Inc. (NASDAQ: QLTI; TSX:,QLT) announced t...ry, has,entered into an asset purchase agreement w... of Allergan, Inc. (NYSE: AGN ) to fully divest Q... the,terms of the agreement, QLT will receive a on...
... sleep has a negative effect on a student academic...ance are different by educational level, according...Monday at SLEEP 2008, the 22nd Annual Meeting of t..., 67 high school, and 64 college students. , Diso...
...nounced that it,has received CE Mark approval for ...new product, which rounds out OrbusNeich,s balloon...d force angioplasty, a technique in,which the forc...t focused force angioplasty is effective in resolv...
...Americans with a family history of colorectal canc...ricans at average risk for the disease. There is a...y history are less likely to be screened than thei...Americans have the highest colorectal cancer (CRC)...
... amateur and,professional athletes competed in the...iathlon Sunday, June 8, with Andy Potts from Color...or the second year in a row.,Featuring a 1.5 mile ...athlons in the world., (Photo: http://www.ne...
Other Medicine News:Health News:Family History Plays Role in Black Colon Screen Rates 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 2Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 3Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 4Health News:QLT announces agreement to sell Aczone(R) to Allergan for approximately US$150 million 5Health News:Sleep variables affecting school performance are different with each educational level 2Health News:OrbusNeich Receives CE Mark Approval for Scoreflex(TM) Coronary Dilatation Catheter 2Health News:Family history and screening for colorectal cancer 2Health News:Defending Champions Andy Potts and Leanda Cave Win 28th Annual Accenture Escape From Alcatraz(TM) Triathlon Sunday, June 8 2
SureStep LH
Clearview Exact Strep A Dipstick
Clearview Exact Strep A Cassette
Inverness Medical Testpack+Plus Strep A with OBC (20 Tests)
Medicine Products: